BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7829266)

  • 1. Inhibition of aberrant crypt growth by non-steroidal anti-inflammatory agents and differentiation agents in the rat colon.
    Wargovich MJ; Chen CD; Harris C; Yang E; Velasco M
    Int J Cancer; 1995 Feb; 60(4):515-9. PubMed ID: 7829266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Piroxicam-induced regression of azoxymethane-induced aberrant crypt foci and prevention of colon cancer in rats.
    Pereira MA; Barnes LH; Steele VE; Kelloff GV; Lubet RA
    Carcinogenesis; 1996 Feb; 17(2):373-6. PubMed ID: 8625466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents.
    Pereira MA; Barnes LH; Rassman VL; Kelloff GV; Steele VE
    Carcinogenesis; 1994 May; 15(5):1049-54. PubMed ID: 8200067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression.
    Wargovich MJ; Jimenez A; McKee K; Steele VE; Velasco M; Woods J; Price R; Gray K; Kelloff GJ
    Carcinogenesis; 2000 Jun; 21(6):1149-55. PubMed ID: 10837003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of retinoids on AOM-induced colon cancer in rats: modulation of cell proliferation, apoptosis and aberrant crypt foci.
    Zheng Y; Kramer PM; Lubet RA; Steele VE; Kelloff GJ; Pereira MA
    Carcinogenesis; 1999 Feb; 20(2):255-60. PubMed ID: 10069462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the rat.
    Wargovich MJ; Chen CD; Jimenez A; Steele VE; Velasco M; Stephens LC; Price R; Gray K; Kelloff GJ
    Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):355-60. PubMed ID: 9162301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention by chemopreventive agents of azoxymethane-induced foci of aberrant crypts in rat colon.
    Pereira MA; Khoury MD
    Cancer Lett; 1991 Dec; 61(1):27-33. PubMed ID: 1837244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of colon cancer and modulation of aberrant crypt foci, cell proliferation, and apoptosis by retinoids and NSAIDs.
    Pereira MA
    Adv Exp Med Biol; 1999; 470():55-63. PubMed ID: 10709674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of d-limonene on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats.
    Kawamori T; Tanaka T; Hirose Y; Ohnishi M; Mori H
    Carcinogenesis; 1996 Feb; 17(2):369-72. PubMed ID: 8625465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention by retinoids of azoxymethane-induced tumors and aberrant crypt foci and their modulation of cell proliferation in the colon of rats.
    Zheng Y; Kramer PM; Olson G; Lubet RA; Steele VE; Kelloff GJ; Pereira MA
    Carcinogenesis; 1997 Nov; 18(11):2119-25. PubMed ID: 9395211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Termination of piroxicam treatment and the occurrence of azoxymethane-induced colon cancer in rats.
    Li H; Kramer PM; Lubet RA; Steele VE; Kelloff GJ; Pereira MA
    Cancer Lett; 1999 Dec; 147(1-2):187-93. PubMed ID: 10660105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-carcinogenic properties of omeprazole against human colon cancer cells and azoxymethane-induced colonic aberrant crypt foci formation in rats.
    Patlolla JM; Zhang Y; Li Q; Steele VE; Rao CV
    Int J Oncol; 2012 Jan; 40(1):170-5. PubMed ID: 21956158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant crypt foci in the colonic mucosa of rats treated with a genotoxic and nongenotoxic colon carcinogen.
    Whiteley LO; Hudson L; Pretlow TP
    Toxicol Pathol; 1996; 24(6):681-9. PubMed ID: 8994294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoprevention of azoxymethane-induced rat aberrant crypt foci by dietary zerumbone isolated from Zingiber zerumbet.
    Tanaka T; Shimizu M; Kohno H; Yoshitani S; Tsukio Y; Murakami A; Safitri R; Takahashi D; Yamamoto K; Koshimizu K; Ohigashi H; Mori H
    Life Sci; 2001 Sep; 69(16):1935-45. PubMed ID: 11693274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoprevention of colonic aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor.
    Rao CV; Kawamori T; Hamid R; Reddy BS
    Carcinogenesis; 1999 Apr; 20(4):641-4. PubMed ID: 10223193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemopreventive effect of aspirin on growth of aberrant crypt foci in rats.
    Shpitz B; Bomstein Y; Kariv N; Shalev M; Buklan G; Bernheim J
    Int J Colorectal Dis; 1998; 13(4):169-72. PubMed ID: 9810521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of azoxymethane-induced aberrant crypt foci in rat colon by nimesulide, a selective inhibitor of cyclooxygenase 2.
    Takahashi M; Fukutake M; Yokota S; Ishida K; Wakabayashi K; Sugimura T
    J Cancer Res Clin Oncol; 1996; 122(4):219-22. PubMed ID: 8601574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of caffeic acid esters on azoxymethane-induced biochemical changes and aberrant crypt foci formation in rat colon.
    Rao CV; Desai D; Simi B; Kulkarni N; Amin S; Reddy BS
    Cancer Res; 1993 Sep; 53(18):4182-8. PubMed ID: 8364913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth kinetics and chemoprevention of aberrant crypts in the rat colon.
    Wargovich MJ; Harris C; Chen CD; Palmer C; Steele VE; Kelloff GJ
    J Cell Biochem Suppl; 1992; 16G():51-4. PubMed ID: 1469905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucin-depleted foci (MDF) in the colon of rats treated with azoxymethane (AOM) are useful biomarkers for colon carcinogenesis.
    Femia AP; Dolara P; Caderni G
    Carcinogenesis; 2004 Feb; 25(2):277-81. PubMed ID: 14604897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.